Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Planet 13 Announces Full Year 2019 Financial Results and Q1 2020 Revenue


      News provided by

      Planet 13 Holdings Inc.

      Apr 14, 2020, 16:30 ET

      Share this article

      Share this article


      • 2019 Revenue of $63.6 million
      • SuperStore accounted for 9.1% of all Nevada cannabis dispensary revenue in 20191
      • 2019 EBITDA of $9.9 million
      • Q1 2020 Revenue of $16.6 million

      All figures are reported in United States dollars ($) unless otherwise indicated

      LAS VEGAS, April 14, 2020 /PRNewswire/ - Planet 13 Holdings Inc. (CSE: PLTH) (OTCQB: PLNHF) ("Planet 13" or the "Company"), a leading vertically-integrated Nevada cannabis company, today announced financial results for the three-month and twelve-month periods ended December 31, 2019. Planet 13's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

      Larry Scheffler, Co-CEO of Planet 13 commented, "Over the past month, businesses across the country have had to quickly adjust to the reality of COVID-19 related restrictions, and Planet 13 has been no exception. While this has impacted our day to day operations, we are approaching this challenge as an opportunity to deliver safe and responsible cannabis to our community. When cannabis dispensaries in Nevada were told to close, we pivoted to focus on our delivery business, and in only 25 days we've ramped our delivery service from five to twenty-eight vehicles and have shifted our customer mix from 15% local area residents, to 100%."

      Mr. Scheffler continued, "While tourism will continue to be a strong driver of our business when things return to normal, this is a unique opportunity for us to build a strong local base and gain lasting market share as we become a fixture in the daily lives of Las Vegas Valley residents.

      Bob Groesbeck, Co-CEO added, "We opened Phase II of the SuperStore during Q4 and are pleased to report that as projected, it drove increased traffic, customer engagement, and higher average ticket. Through Q4, a seasonally slow period, we delivered $16.5 million in revenue. During Q1 2020, we saw the network effect of Phase II accelerate, resulting in ~$16.6 million in revenue, a 20% increase compared to Q1 of 2019, despite effects of COVID-19 starting in the middle of March. In addition, the customer-facing production facility is fully ramped up and we have begun to offer Planet 13's portfolio of in-house brands to select third-party dispensaries on a wholesale basis."

      _________________________

      1 https://tax.nv.gov/uploadedFiles/taxnvgov/Content/TaxLibrary/NV-Marijuana-Revenue-FY20(4).pdf

      Financial Highlights – Q4 – 2019

      Operating Results

      All comparisons below are to the quarter ended December 31, 2018, unless otherwise noted

      • Revenues were $16.5 million as compared to $8.3 million, an increase of 99.8%
      • Gross profit before biological adjustments was $9.4 million or 57.1% as compared $4.2 million or 50.5%, an increase of 125.8%
      • Operating expenses, excluding non-cash compensation expense, were $7.1 million as compared to $5.8 million, an increase of 21.5%
      • Net loss before taxes of $0.9 million as compared to a net loss of $2.2 million
      • Net loss of $2.6 million as compared to a net loss of $3.1 million
      • Adjusted EBITDA of $2.5 million as compared to Adjusted EBITDA loss of $1.5 million

      Balance Sheet

      All comparisons below are to December 31, 2018, unless otherwise noted

      • Cash of $12.8 million as compared to $19.4 million
      • Total assets of $62.9 million as compared to $44.9 million
      • Total liabilities of $21.6 million as compared to $7.0 million

      Financial Highlights – Full Year – 2019

      All comparisons below are to the year ended December 31, 2018, unless otherwise noted

      • Revenues were $63.6 million as compared to $21.2 million, an increase of 200.4%
      • Gross profit before biological adjustments was $36.5 million or 57.3% as compared $10.7 million or 50.4%, an increase of 242.0%
      • Operating expenses, excluding non-cash compensation expense, were $26.8 million as compared to $11.3 million, an increase of 137.5%
      • Net income before taxes of $0.5 million as compared to a net loss of $8.4 million
      • Net loss of $6.7 million as compared to a net loss of $10.7 million
      • Adjusted EBITDA of $9.9 million as compared to Adjusted EBITDA loss of $367,874

      Q4 Highlights and Recent Developments

      For a more comprehensive overview of these highlights and recent developments, please refer to Planet 13's Management's Discussion and Analysis of the Financial Condition and Results of Operations for the Three and Twelve Months Ended December 31, 2019 (the "MD&A").  

      • On November 1, 2019, Planet 13 announced the opening of the customer-facing production facility.
      • On December 16, 2019, Planet 13 announced winning U.S. Market Leader Award in Retail at MJBizCon.
      • On January 20, 2020, Planet 13 announced the opening of dosist™ shop-in-shop wellness experience.
      • On March 19, 2020, Planet 13 announced offering expanded online ordering and delivery services.
      • On March 23, 2020, Planet 13 announced 24-hour delivery service.
      • On April 13, 2020, Planet 13 announced termination of Santa Ana acquisition.

      Results of Operations (Summary)

      The following tables set forth consolidated statements of financial information for the three-month and twelve-month period ending December 31, 2019 and December 31, 2018. For further information regarding the Company's financial results for these periods, please refer to the Company's interim financial statements for the period ended December 31, 2019 together with the MD&A, available on Planet 13's issuer profile on SEDAR at www.sedar.com and the Company's website https://www.planet13holdings.com.

      Adjusted EBITDA



      NV Cannabis Ops


      Consolidated






      NV Cannabis Ops


      Consolidated







      Three Months


      Three Months


      Three Months




      Year


      Year


      Year





      Ended


      Ended


      Ended


      Percentage


      Ended


      Ended


      Ended


      Percentage



      Dec-31-2019


      Dec-31-2019


      Dec-31-2018


      Change


      Dec-31-2019


      Dec-31-2019


      Dec-31-2018


      Change

      EBITDA
















      Profit (loss) before taxes


      1,416,699


      (914,960)


      (2,215,973)


      (58.7%)


      8,422,424


      542,664


      (8,433,501)


      (106.4%)

      Add back:

















         Biological asset adjustments


      351,080


      351,080


      (108,084)


      (424.8%)


      480,181


      480,181


      (192,908)


      (348.9%)

         Non-cash share based payments


      -


      1,694,370


      367,497


      361.1%


      -


      4,822,787


      2,601,233


      85.4%

         Depreciation and amortization


      900,278


      900,278


      332,925


      170.4%


      2,845,464


      2,845,464


      400,116


      611.2%

         Depreciation included in COGS


      157,030


      157,030


      141,205


      11.2%


      286,987


      286,987


      258,788


      10.9%

         Interest and non-operating expense (income)


      329,291


      329,291


      (24,928)


      (1421.0%)


      954,960


      954,960


      4,998,398


      (80.9%)


















      EBITDA

      3,154,378


      2,517,089


      (1,507,358)


      267.0%


      12,990,016


      9,933,043


      (367,874)


      2800.1%

       Margin

      19.1%


      15.2%


      (18.2%)




      20.4%


      15.6%


      (1.7%)















      Expressed in USD$

      Three

       Months


      Three

       Months




      Year


      Year





      Ended


      Ended


      Percentage


      Ended


      Ended


      Percentage



      Dec-31-2019


      Dec-31-2018


      Change


      Dec-31-2019


      Dec-31-2018


      Change

      Revenue












      Revenues, net of discounts

      16,540,324


      8,279,698


      99.8%


      63,595,036


      21,166,755


      200.4%

      Cost of Goods Sold

      (7,098,908)


      (4,097,973)


      73.2%


      (27,139,658)


      (10,507,200)


      158.3%

      Gross Profit, Before Biological Asset Adjustment


      9,441,416


      4,181,725


      125.8%


      36,455,378


      10,659,555


      242.0%

      Gross Profit Margin %


      57.1%


      50.5%




      57.3%


      50.4%



      Realized fair value amounts included in COGS

      (695,361)


      207,865


      (434.5%)


      (1,500,965)


      (1,726,685)


      (13.1%)

      Unrealized fair value gain on growth of biological assets

      344,281


      (99,781)


      (445.0%)


      1,020,784


      1,919,593


      (46.8%)

      Gross profit


      9,090,336


      4,289,809


      111.9%


      35,975,197


      10,852,463


      231.5%

      Gross Profit Margin %


      55.0%


      51.8%




      56.6%


      51.3%
















      Expenses












      General and Administrative

      5,351,056


      4,682,652


      14.3%


      20,269,839


      9,583,376


      111.5%

      Sales and Marketing

      1,730,301


      1,147,636


      50.8%


      6,539,483


      1,702,841


      284.0%

      Depreciation and Amortization

      900,278


      332,925


      170.4%


      2,845,464


      400,116


      611.2%

      Share based payments

      1,694,370


      367,497


      361.1%


      4,822,787


      2,601,233


      85.4%

      Total Expenses

      9,676,005


      6,530,710


      48.2%


      34,477,573


      14,287,566


      141.3%














      Income (Loss) From Operations 

      (585,669)


      (2,240,901)


      (73.9%)


      1,497,624


      (3,435,103)


      (143.6%)














      Other (Income) Expense:













      Interest Expense, net


      404,332


      5,674


      7026.0%


      1,306,876


      241,860


      440.3%

      Realized Foreign Exchange gain (loss)


      -


      (4,376)


      (100.0%)


      (1,141)


      37,879


      (103.0%)

      RTO acquisition costs


      -


      -


      na


      -


      4,702,604


      na

      Other expense (income)


      (75,041)


      (26,226)


      186.1%


      (350,775)


      (80,285)


      336.9%

      Loss on settlement of accounts payable (Note 13(d))


      -


      -


      na


      -


      96,340


      na

      Total Other Expense (Income)


      329,291


      (24,928)


      (1421.0%)


      954,960


      4,998,398


      (80.9%)














      Income (loss) for the period before tax


      (914,960)


      (2,215,973)


      (58.7%)


      542,664


      (8,433,501)


      (106.4%)

      Provision for income tax (current and deferred)


      1,662,213


      889,066


      87.0%


      7,200,997


      2,290,203


      214.4%

      (Loss) for the period


      (2,577,173)


      (3,105,039)


      (17.0%)


      (6,658,333)


      (10,723,704)


      (37.9%)














      Other Comprehensive Income (Loss)












      Items that may be reclassified subsequently to profit/loss 












           Foreign exchange translation adjustment

      (24,607)


      (666,969)




      195,213


      (802,920)



      Net Comprehensive (Loss) for the period

      (2,601,780)


      (3,772,008)




      (6,463,120)


      (11,526,624)



      (Loss) per share for the period













      Basic and fully diluted loss per share


      ($0.02)


      ($0.02)




      ($0.05)


      ($0.11)
















      Weighted Average Number of Shares Outstanding













      Basic and fully diluted


      135,888,982


      128,166,081




      134,074,476


      95,997,827



      Outstanding Shares

      As at the date of this report, the Company had 84,451,832 common shares and 55,232,940 class A convertible, restricted voting shares issued and outstanding for a total of 139,684,772 shares outstanding.  There were 558,507 options issued and outstanding of which 250,834 have fully vested.  There were 13,572,238 warrants outstanding and 3,454,589 RSU's outstanding of which nil RSUs had fully vested as at the date of this report.

      Conference Call

      Planet 13 will host a conference call on Tuesday, April 14, 2020 at 5:00 p.m. EST to discuss its third quarter financial results and provide investors with key business highlights.  The call will be chaired by Bob Groesbeck, Co-CEO, Larry Scheffler, Co-CEO, and Dennis Logan, CFO. 

      CONFERENCE CALL DETAILS

      Date: April 14, 2020 | Time: 5:00 p.m. EST
      Participant Dial-in: 416-764-8688 or 1-888-390-0546
      Replay Dial-in: 416-764-8677 or 1-888-390-0541
      (Available for 2 weeks)
      Reference Number: 656850
      Listen to webcast: https://bit.ly/3dUnQs2 

      Financial Measures

      There are measures included in this news release that do not have a standardized meaning under generally accepted accounting principles (GAAP) and therefore may not be comparable to similarly titled measures and metrics presented by other publicly traded companies. The Company includes these measures because it believes certain investors use these measures and metrics as a means of assessing financial performance. EBITDA (earnings before interest, taxes, depreciation and amortization) is calculated as net earnings before finance costs (net of finance income), income tax expense, and depreciation and amortization of intangibles and is a non-GAAP financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies.

      About Planet 13
      Planet 13 (www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas - the entertainment capital of the world. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13's shares trade on the Canadian Stock Exchange (CSE) under the symbol PLTH and OTCQX under the symbol PLNHF.

      Cautionary Note Regarding Forward-Looking Information

      This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking statements relate to, among other things, future expansion plans.

      These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada and California cannabis markets and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the States of Nevada and California; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

      The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through its subsidiary MM Development Company, Inc. ("MMDC") in Nevada. Local state laws where MMDC operates permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated April 30, 2019 filed on its issuer profile on SEDAR at www.sedar.com.

      No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

      CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION






      Expressed in United States Dollars


      As at


      As at



      December 31,


      December 31,



      2019


      2018

      Assets





      Current Assets





      Cash 


      $

      12,814,712


      $

      19,364,086

      HST receivable


      16,544


      101,831

      Inventories 


      5,474,004


      5,322,111

      Biological assets 


      514,526


      915,177

      Prepaid expenses and other current assets 


      3,694,272


      1,391,278

      Total Current Assets


      22,514,058


      27,094,483






      Property and equipment 


      30,211,154


      17,256,484

      Right of use assets 


      9,478,733


      -

      Long-term deposits and other assets 


      694,601


      594,339



      40,384,488


      17,850,823

      Total Assets


      $

      62,898,546


      $

      44,945,306






      Liabilities





      Current Liabilities





      Accounts payable


      $

      864,260


      $

      1,720,721

      Accrued expenses


      1,910,046


      1,306,145

      Income taxes payable


      7,015,606


      2,187,109

      Notes payable - current portion


      884,000


      884,000

      Current portion of lease liabilities 


      -


      14,459

      Total Current Liabilities


      10,673,912


      6,112,434






      Long -term lease liabilities 


      10,522,377


      29,768

      Deferred rent 


      -


      427,508

      Other long-term liabilities


      28,000


      -

      Deferred tax liability


      379,665


      470,856



      10,930,042


      928,132

      Total Liabilities


      21,603,954


      7,040,566






      Shareholders' Equity





      Share capital 


      51,986,849


      42,460,824

      Restricted share units


      4,119,485


      2,800,335

      Warrants 


      5,961,091


      7,046,843

      Option reserve 


      399,439


      305,890

      Accumulated other comprehensive loss


      (607,707)


      (802,920)

      Deficit


      (20,564,565)


      (13,906,232)

      Total Shareholders' Equity


      41,294,592


      37,904,740

      Total Liabilities and Shareholders' Equity


      $

      62,898,546


      $

      44,945,306

      CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)










      Expressed in United States Dollars


      Year


      Year


      Three months


      Three months



      Ended


      Ended


      Ended


      Ended



      December 31,


      December 31,


      December 31,


      December 31,



      2019


      2018


      2019


      2018

      Revenue









      Revenues, net of discounts


      $

      63,595,036


      $

      21,166,755


      $

      16,540,324


      $

      8,279,698

      Cost of Goods Sold 


      (27,139,658)


      (10,507,200)


      (7,098,908)


      (4,097,973)

      Gross Profit before fair value asset adjustment


      36,455,378


      10,659,555


      9,441,416


      4,181,725

      Realized fair value amounts included in inventory sold


      (1,500,965)


      (1,726,685)


      (695,361)


      207,865

      Unrealized fair value gain on growth of biological assets


      1,020,784


      1,919,593


      344,281


      (99,781)

      Gross Profit


      35,975,197


      10,852,463


      9,090,336


      4,289,809










      Expenses









      General and Administrative 


      20,269,839


      9,583,376


      5,351,056


      4,682,652

      Sales and Marketing


      6,539,483


      1,702,841


      1,730,301


      1,147,636

      Depreciation and Amortization 


      2,845,464


      400,116


      900,278


      332,925

      Share-Based Compensation Expense 


      4,822,787


      2,601,233


      1,694,370


      367,497

      Total Expenses


      34,477,573


      14,287,566


      9,676,005


      6,530,710










      Income (Loss) From Operations 


      1,497,624


      (3,435,103)


      (585,669)


      (2,240,901)










      Other Expense:









      Interest expense, net


      1,306,876


      241,860


      404,332


      5,674

      Realized foreign exchange (gain) loss


      (1,141)


      37,879


      -


      (4,376)

      Other income


      (350,775)


      (80,285)


      (75,041)


      (26,226)

      RTO listing expense 


      -


      4,702,604


      -


      -

      Loss on settlement of accounts payable


      -


      96,340


      -


      -

      Total Other Expense


      954,960


      4,998,398


      329,291


      (24,928)










      Income (Loss) before income taxes


      542,664


      (8,433,501)


      (914,960)


      (2,215,973)

      Provision for tax - current 


      7,292,188


      2,198,295


      1,402,227


      909,107

      Provision for tax - deferred


      (91,191)


      91,908


      259,986


      (20,041)

      Net (loss) for the Year


      $

      (6,658,333)


      $

      (10,723,704)


      $

      (2,577,173)


      $

      (3,105,039)










      Other Comprehensive Income (Loss)


















           Foreign exchange translation gain (loss)


      195,213


      (802,920)


      (24,607)


      (666,969)

      Net Comprehensive  (Loss) for the Year


      $

      (6,463,120)


      $

      (11,526,624)


      $

      (2,601,780)


      $

      (3,772,008)










      Loss per share for the Year









      Basic and diluted loss per share 


      ($0.05)


      ($0.11)


      ($0.02)


      ($0.02)










      Weighted Average Number of Common Shares Outstanding









      Basic and Diluted (Note 17)


      134,074,476


      95,997,827


      135,888,982


      128,166,081










      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS






      Expressed in United States Dollars


      Year


      Year



      Ended


      Ended



      December 31,


      December 31,



      2019


      2018

      Operating activities





      Net (loss) for the year


      $

      (6,658,333)


      $

      (10,723,704)

      Add (deduct) non-cash items:





      Share based payments 


      4,822,787


      2,601,233

      Depreciation and amortization 


      3,607,286


      988,768

        Write-off of fixed assets duringthe year


      82,882


      -

      Loss on settlement of accounts payable


      -


      96,340

      Share base payment to Carpincho shareholders on RTO


      -


      4,040,637

      Deferred tax liability 


      (91,191)


      91,908

      Realized foreign exchange (gain) loss


      -


      37,879

      Interst on lease  liabilities


      1,367,759


      -

      Non-cash interest expense


      -


      217,048






      Net change in non-cash working capital





      HST receivable


      85,287


      (101,831)

      Inventories 


      (151,893)


      (3,618,283)

      Biological assets 


      400,651


      152,129

      Prepaid expenses and other assets 


      (2,426,866)


      (1,299,148)

      Long term deposits and other assets


      (100,262)


      (594,339)

      Accounts payable 


      (856,462)


      798,672

      Accrued expenses


      603,902


      250,318

      Income tax payable


      4,828,497


      927,433

      Other liabilities


      28,000


      427,508

      Cash flow provided by (used in) operating activities


      5,542,044


      (5,707,432)






      Investing activities





      Net cash acquired on acquisition


      -


      34,678

      Purchase of property, plant and equipment 


      (16,061,582)


      (13,313,401)

      Cash flow used in investing activities


      (16,061,582)


      (13,278,723)






      Financing activities





      Issuance of common shares and warrants 


      -


      40,381,022

      Issuance of shares on warrant and option exercises 


      5,030,185


      2,374,253

      Share and warrant issuance costs


      -


      (4,032,025)

      Principal and interest payment on lease liabilities


      (1,247,546)


      (11,845)

      Cash flow provided by financing activities


      3,782,639


      38,711,405






      Net increase (decrease) in cash 


      (6,736,899)


      19,725,250

      Cash  at beginning of the year


      19,364,086


      451,869

      Effect of foreign exchange on cash


      187,525


      (813,033)

      Cash at end of the year


      $

      12,814,712


      $

      19,364,086

      SOURCE Planet 13 Holdings Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.